Viz.ai Raises $50 Million Series B Round to Bring AI Powered Synchronized Stroke Care to More Patients
Summary
SAN FRANCISCO & TEL AVIV, Israel--(BUSINESS WIRE)--Viz.ai, the developer of the first synchronized healthcare software (Viz) using artificial intelligence (AI), today announced a $50 million Series B funding. The funding round was led by Greenoaks with participation from Threshold Ventures, CRV along with existing investors GV and Kleiner Perkins. Viz.ai is reducing the impact of this devastating disease and saving lives,” said J Mocco1, MD, Professor and Vice Chair of the Department of Neurosurgery, Mount Sinai Health System. Viz.ai’s flagship product, Viz LVO, leverages advanced deep learning to communicate time-sensitive information about suspected stroke patients straight to a specialist who can intervene and treat. Viz.ai announced its second FDA clearance for Viz CTP through the 510(k) pathway, offering healthcare providers an important tool for automated cerebral perfusion image analysis.